Rezolute (RZLT) Total Current Liabilities (2011 - 2026)
Rezolute (RZLT) posted Total Current Liabilities of $7.7 million for Q1 2026, down 19.19% sequentially from $9.5 million in Q4 2025, and down 26.67% YoY from $10.5 million in Q1 2025.
Rezolute (RZLT) Total Current Liabilities (2011 - 2026) Analysis & Trends
Rezolute has reported Total Current Liabilities for 16 years, with the latest figure at $7.7 million in Q1 2026.
- Quarterly Total Current Liabilities fell 26.67% year-over-year to $7.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.7 million (down 26.67% YoY) and the FY2025 annual result came in at $11.9 million, up 24.01% from the prior year.
- Total Current Liabilities fell to $7.7 million in Q1 2026 per RZLT's latest filing, from $9.5 million in the prior quarter.
- Over five years, Total Current Liabilities peaked at $11.9 million in Q2 2025 and troughed at $2.4 million in Q3 2022.
- A 5-year average of $7.3 million and a median of $7.7 million in 2026 frame the typical range for Total Current Liabilities.
- The sharpest annual moves came in 2023 and 2026: Total Current Liabilities jumped 200.0% in 2023, then dropped 26.67% in 2026.
- Over 5 years, Total Current Liabilities stood at $6.3 million in 2022, then advanced by 27.11% to $8.0 million in 2023, then jumped by 32.37% to $10.6 million in 2024, then fell by 10.1% to $9.5 million in 2025, then fell by 19.19% to $7.7 million in 2026.
- According to Business Quant data, Total Current Liabilities over the past three periods registered $7.7 million, $9.5 million, and $10.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.58 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 354.06 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 2.12 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4.22 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 630.93 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.51 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 438.74 Mn |
| 10 | Rezolute | 442.94 Mn | 442.94 Mn | - | 7.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.70 Mn |
| Dec 31, 2025 | 9.53 Mn |
| Sep 30, 2025 | 10.20 Mn |
| Jun 30, 2025 | 11.91 Mn |
| Mar 31, 2025 | 10.50 Mn |
| Dec 31, 2024 | 10.60 Mn |
| Sep 30, 2024 | 8.00 Mn |
| Jun 30, 2024 | 9.61 Mn |
| Mar 31, 2024 | 6.96 Mn |
| Dec 31, 2023 | 8.01 Mn |
| Sep 30, 2023 | 7.20 Mn |
| Jun 30, 2023 | 5.20 Mn |
| Mar 31, 2023 | 4.39 Mn |
| Dec 31, 2022 | 6.30 Mn |
| Sep 30, 2022 | 2.40 Mn |
| Jun 30, 2022 | 2.46 Mn |
| Mar 31, 2022 | 2.90 Mn |
| Dec 31, 2021 | 6.40 Mn |
| Sep 30, 2021 | 2.60 Mn |
| Jun 30, 2021 | 1.97 Mn |